News for hackers. Stuff that matters.
Re:U.S. lawmakers ask Gilead to justify hepatitis C drug's $... by jacquesm on Friday April 04, 2014 @04:47AM (#7530075)
I find it funny to see this on the same front page as the one where the tarsnap founder is being told how he can make lots of money.

You can't have it both ways folks, either you charge 'by value' or you charge 'by cost'. If you follow the advice of 'charge as much as the market will bear' for medication you get this situation, if you follow the cost+ model and apply it to backup you get tarsnap (assuming you know enough about medicine to come up with the medication and enough about crypto and assorted bits and pieces of computer programming to be able to create a secure backup service).

Applying charging by value to tarsnap and cost+ to medicine is telling people that they should go and study ethics, and business people are notoriously bad at ethics.

As long as medicine and money are intricately involved (and as a motivator, money seems to be doing a pretty good job) you'll have excesses like these. Life is literally priceless and we're addicted to it, what better product than one that costs little to produce and has a 90% chance of improving the chances of the taker afflicted with some horrible disease to prolong their lives. It's any marketeer/greedy s.o.b'es wet dream.

That's all the justification they'll ever need.

There are no comments on this comment yet.